148
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

A cationic cyclodextrin derivative-lipid hybrid nanoparticles for gene delivery effectively promotes stability and transfection efficiency

, , , , , & show all
Pages 1-11 | Received 11 Aug 2021, Accepted 15 Mar 2022, Published online: 29 Jun 2022

References

  • Lapteva L, Purohit-Sheth T, Serabian M, et al. Clinical development of gene therapies: the first three decades and counting. Mol Ther Methods Clin Dev. 2020;19:387–397.
  • High KA. Turning genes into medicines-what have we learned from gene therapy drug development in the past decade. Nat Commun. 2020;11(1):5821.
  • Goverdhana S, Puntel M, Xiong W, et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther. 2005;12(2):189–211.
  • Schmidt-Wolf GD, Schmidt-Wolf IG. Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol Med. 2003;9(2):67–72.
  • Wang C, Luo X, Zhao Y, et al. Influence of the polyanion on the physico-chemical properties and biological activities of polyanion/DNA/polycation ternary polyplexes. Acta Biomater. 2012;8(8):3014–3026.
  • Wang Z, Liang Y, Liu Y, et al. The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC. Drug Dev Ind Pharm. 2020;46(11):1862–1872.
  • Majzoub RN, Ewert KK, Safinya CR. Cationic liposome-nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing. Philos Trans A Math Phys Eng Sci. 2016;374(2072):1–14.
  • Tahir N, Madni A, Balasubramanian V, et al. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Int J Pharm. 2017;533(1):156–168.
  • Dave V, Tak K, Sohgaura A, et al. Lipid-polymer hybrid nanoparticles: synthesis strategies and biomedical applications. J Microbiol Methods. 2019;160:130–142.
  • Ferreira Soares DC, Domingues SC, Viana DB, et al. Polymer-hybrid nanoparticles: current advances in biomedical applications. Biomed Pharmacother. 2020;131:110695.
  • Zhiani M, Mousavi MA, Rostamizadeh K, et al. Apoptosis induction by siRNA targeting integrin-beta1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant Colon cancer cells. Am J Cancer Res. 2021;11(4):1170–1184.
  • Jansen MAA, Klausen LH, Thanki K, et al. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model. Eur J Pharm Biopharm. 2019;142:38–48.
  • Biwer A, Antranikian G, Heinzle E. Enzymatic production of cyclodextrins. Appl Microbiol Biotechnol. 2002;59(6):609–617.
  • Stella VJ, Rao VM, Zannou EA, et al. Mechanisms of drug release from cyclodextrin complexes. Adv Drug Deliv Rev. 1999;36(1):3–16.
  • López CA, de Vries AH, Marrink SJ. Molecular mechanism of cyclodextrin mediated cholesterol extraction. PLoS Comput Biol. 2011;7(3):e1002020.
  • Shelley H, Babu RJ. Role of cyclodextrins in nanoparticle-based drug delivery systems. J Pharm Sci. 2018;107(7):1741–1753.
  • Tian S, Cao D, Zou H, et al. Endothelial cell-targeted pVEGF165 polyplex plays a pivotal role in inhibiting intimal thickening after vascular injury. Int J Nanomedicine. 2015;10:5751–5768.
  • Hayat S, Farahani N, Safdarian E, et al. Gene delivery using lipoplexes and polyplexes: principles, limitations and solutions. Crit Rev Eukaryot Gene Expr. 2019;29(1):29–36.
  • Sparks J, Slobodkin G, Matar M, et al. Versatile cationic lipids for siRNA delivery. J Control Release. 2012;158(2):269–276.
  • Buyens K, De Smedt SC, Braeckmans K, et al. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release. 2012;158(3):362–370.
  • Zhang L, Zhang L. Lipid polymer hybrid nanoparticles: synthesis, characterization, and applications. Nano Life. 2010;01(01n02):163–173. ):
  • Hasan M, Ben Messaoud G, Michaux F, et al. Chitosan-coated liposomes encapsulating curcumin: study of lipid–polysaccharide interactions and nanovesicle behavior. RSC Adv. 2016;6(51):45290–45304.
  • Wen Y, Guo Z, Du Z, et al. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. Biomaterials. 2012;33(32):8111–8121.
  • Huang H, Cao D, Qin L, et al. Dilution-stable PAMAM G1-grafted polyrotaxane supermolecules deliver gene into cells through a caveolae-dependent pathway. Mol Pharm. 2014;11(7):2323–2333.
  • Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009;66(17):2873–2896.
  • Rappoport JZ. Focusing on clathrin-mediated endocytosis. Biochem J. 2008;412(3):415–423.
  • Hemp ST, Allen MJ, Green MD, et al. Phosphonium-containing polyelectrolytes for nonviral gene delivery. Biomacromolecules. 2012;13(1):231–238.
  • Rejman J, Bragonzi A, Conese M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther. 2005;12(3):468–474.
  • Rejman J, Conese M, Hoekstra D. Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J Liposome Res. 2006;16(3):237–247.
  • Xiang S, Tong H, Shi Q, et al. Uptake mechanisms of non-viral gene delivery. J Control Release. 2012;158(3):371–378.
  • Wightman L, Kircheis R, Rossler V, et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 2001;3(4):362–372.
  • Cho YW, Kim JD, Park K. Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol. 2003;55(6):721–734.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.